Tissue specificity of cAMP‐phosphodiesterase inhibitors: Rolipram, amrinone, milrinone, enoximone, piroximone, and imazodan
- 1 January 1988
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 14 (2) , 141-149
- https://doi.org/10.1002/ddr.430140205
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitorsBiochemical Journal, 1987
- The Effect of the Cardiotonic Imazodan (CI-914) on Myocardial and Peripheral Hemodynamics in the Anesthetized DogJournal of Cardiovascular Pharmacology, 1986
- Selective inhibition of one of the cyclic AMP phosphodiesterases from rat brain by the neurotropic compound rolipramBiochemical Pharmacology, 1985
- A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug SelectivityJournal of Medicinal Chemistry, 1985
- Responses to Amrinone in Isolated Cardiac Muscles from Cat, Rabbit, and Guinea PigJournal of Cardiovascular Pharmacology, 1984
- Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental AnimalsJournal of Cardiovascular Pharmacology, 1983
- Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitorsNeuropharmacology, 1983
- Cardiovascular Properties of a New Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1982
- Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].Circulation Research, 1979
- Rapid assay for cyclic AMP and cyclic GMP phosphodiesterasesAnalytical Biochemistry, 1978